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The cross-talk among cells of the innate immunity can greatly affect
both innate and adaptive responses. Here we analyzed the
molecular interactions between human natural killer (NK) cells
and autologous macrophages. Activated NK cells killed M0 and
M2, whereasM1macrophagesweremore resistant to lysis because
of their higher expression of HLA class I molecules. Following
exposure to LPS or bacillus Calmette–Guérin, M0 and M2, but not
polarized (endotoxin tolerant) M1 macrophages, induced strong
activation of resting NK cells. The expression of CD69 and CD25
activation markers and the acquisition of cytotoxicity against
tumor cells and immature dendritic cells required soluble factors
being mostly contact independent. On the contrary, IFN-γ produc-
tionwas contact dependent and required the interaction of DNAM-
1 and 2B4 (on NK) with their ligands on macrophages as well as IL-
18. IL-18 was involved also in the acquisition of CCR7 by NK cells.
Interestingly, M0 and M2 cells expressed a membrane-bound form
of IL-18, which was released in small amounts after LPS treatment.
Our data indicate that, upon interaction with M0 macrophages ex-
posed to microbial products, NK cells may amplify classical type 1
immune responses. In addition,M1-polarizing stimuli can rescueM2
macrophages from their immunomodulatory state and shape their
functional behavior toward NK stimulatory capability.
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Natural killer (NK) cells play an important role in immuneresponses against cancer and pathogen infections by exert-
ing potent cytolytic activity and producing large amounts of T-
helper (Th1) cytokines such as IFN-γ. NK cell activation may be
induced by IL-12, IL-15, and IL-18 (1) and by the interaction
between activating NK receptors and their ligands on target cells.
In humans, activating receptors include NKp46, NKp30, and
NKp44 (collectively termed natural cytotoxicity receptors, NCR),
DNAM-1, and NKG2D (2, 3), whereas NKp80, 2B4, and NTBA
are generally considered coreceptors (2, 4). Different cellular
ligands have been identiﬁed (5). DNAM-1 recognizes PVR and
Nectin-2, two Nectin family members that are overexpressed in
tumors (6, 7), and NKG2D interacts with MICA/B and ULBP.
2B4 interacts with CD48, NKp80 recognizes the activation-
induced C-type lectin (AICL) (8), and NTBA displays homophilic
interaction. The NCR cellular ligands are not fully deﬁned, and
only recently NKp30 has been shown to interact with B7-H6,
a tumor-associated surface molecule that represents a novel mem-
ber of the B7 family (9).
The function of the activating receptors/coreceptors is under the
control of inhibitory receptors that recognize HLA class I mole-
cules on potential targets (2, 10). These receptors include CD94/
NKG2A, which recognizes nonclassical HLA-E molecules and the
killer Ig-like receptors (KIR, CD158), speciﬁc for allotypic deter-
minants shared by groups of classical HLA-A, -B, and -C alleles.
The survival or death of a potential target depends on the type
and the number of receptor/ligand interactions occurring at the
NK/target cell immune synapse. In an autologous setting, normal
cells are spared from NK-mediated killing because of the ex-
pression of high (protective) amounts of self-HLA class I mol-
ecules and of the lack of (or low) expression of ligands for
activating NK receptors. However, tumors become susceptible to
killing mediated by autologous NK cells because of a defective
(nonprotective) expression of HLA class I molecules and de
novo expression or up-regulation of ligands for activating NK
receptors (6, 7, 9, 11, 12).
During inﬂammation, NK cells, after extravasation and re-
cruitment into tissues in response to chemokine gradients, can
interact with other immune cell types (13). These interactions
may play a critical role not only during early innate immune
responses but also in the initiation, ampliﬁcation, and polariza-
tion of adaptive responses. For example, a bidirectional cross-
talk occurs between NK and monocyte-derived dendritic cells
(DCs) (14). As DCs, macrophages are crucial components of
innate immunity. During inﬂammatory responses, monocytes are
recruited into tissues, skewed toward macrophages (M0) by
chemokines and growth factors, and polarized toward M1 or M2
functional phenotype (15, 16).
M1 and M2 macrophages represent the two extreme of a spec-
trum. In vitro, M1 polarization can be induced by IFN-γ alone or
in concert with microbial stimuli such as LPS, whereas M2 po-
larization requires IL-4 or IL-13. M1 and M2 display different
cytokine and chemokine gene expression proﬁles and functional
properties (15). M1 are characterized by IL-12high, IL-23high, and
IL-10low, whereas M2 macrophages have an IL-12-low, IL-23low,
IL-10high, CD206high, and scavenger receptorshigh transcription
proﬁles. In general, M1 macrophages have immunostimulatory
Th1-orienting properties, kill intracellular pathogens, and have
antitumoral activity. M2 cells have poor Ag-presenting capacity;
promote angiogenesis, tissue remodeling, and repair; and suppress
Th1 adaptive immunity while supporting TH2 responses necessary
for killing and encapsulation of parasites.
Macrophages are the most represented leukocytes in cancer
tissues and in established progressing tumors generally have M2-
like phenotype (17). Cancer cells, by secreting a wide spectrum of
soluble factors, attract circulating monocytes and promote their
differentiation to macrophages while blocking differentiation to
Author contributions: F.B., R.C., and C.B. designed research; F.B. and A.D. performed
research; R.C., G.R., L.M., A. Mantovani, A. Moretta, and C.B. analyzed data; and
A. Mantovani, A. Moretta, and C.B. wrote the paper.
Conﬂict of interest statement: A. Moretta is founder and shareholder of Innate Pharma
(Marseille, France). The remaining authors have no conﬂicting ﬁnancial interests.
This article is a PNAS Direct Submission.
1F.B. and R.C. contributed equally to this work.
2To whom correspondence should be addressed. E-mail: cristina.bottino@unige.it.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1007654108/-/DCSupplemental.
www.pnas.org/cgi/doi/10.1073/pnas.1007654108 PNAS | December 14, 2010 | vol. 107 | no. 50 | 21659–21664
IM
M
U
N
O
LO
G
Y
DCs (18). Importantly, the tumor microenvironment twists the
polarization of tumor-associated macrophages (TAM) toward an
M2-like phenotype that would display strong protumoral activity.
Although NK cells and macrophages are pillars of innate im-
munity, little information is available on their interplay. The
present study was designed to systematically investigate the in-
teraction between different types of macrophages and NK cells
and the molecular pathways involved.
Results
M0 and M2 Are Susceptible to Killing by Autologous Cytokine-
Conditioned NK Cells. To analyze whether NK cells could kill
unpolarized or polarized macrophages, highly puriﬁed NK cells
were used as effectors in cytolytic assays against autologous M0,
M1, and M2 cells or, for comparison, monocyte-derived imma-
ture or mature DCs (iDCs or mDCs; Fig. 1 and Fig. S1).
Freshly puriﬁed (resting) NK cells did not kill either macro-
phages or DCs. However, NK cells that had been activated
overnight with rIL-12 displayed cytolytic activity against M0 and
M2 as well as against iDCs (19, 20). Interestingly, M1, similar to
mDCs, were more resistant to lysis than M0 (P = 0.013) and M2
(P= 0.031; Fig. 1A Left). However, upon disruption of inhibitory
receptors/HLA class I interactions using anti-HLA-class I mAb,
M0, M1, and M2 displayed similar susceptibility to NK-mediated
lysis (Fig. 1A Right). These data suggested an important role of
HLA class I molecules in protecting M1 macrophages from NK
cell-mediated cytotoxicity. Accordingly, the susceptibility to lysis
(M0, M2 > M1) inversely correlated with the level of expression
of both classical and nonclassical HLA class I molecules (M1 >
M2, M0; Fig. 1B and Fig. S1).
To evaluate the contribution of one or another activating NK
receptor in killing of macrophages, cytolytic assays were per-
formed in the presence of mAbs speciﬁc for major activating NK
receptors. As shown in Fig. 1C, NKp46 and DNAM-1 mainly
contributed to the lysis of macrophages. Indeed, mAb-mediated
disruption of their interaction with the speciﬁc ligands on target
cells resulted in signiﬁcant inhibition of lysis. Other activating
receptors and coreceptors contributed only marginally or were
not involved in killing.
Thus, among the activating receptors, NKp46 played a major
role in killing ofmacrophages (Fig. 1C), whereas killing ofDCswas
mainly NKp30 dependent (14). On the other hand, DNAM-1 was
involved in killing of both macrophages (Fig. 1C) and DCs (19).
LPS-Treated M0 and M2 Enhance the Cytolytic Activity of Resting NK
Cells Against K562 and iDCs. We next analyzed whether macro-
phages could induce activation of resting NK cells. In these
experiments, to avoid interferences of cytokines and stimuli used
during differentiation and polarization, M0, M1, and M2 where
washed extensively. After washing, cells were cultured with au-
tologous resting NK cells in either the absence or the presence of
LPS or bacillus Calmette–Guérin. After coculture, NK cells were
recovered (>99% purity) and analyzed for cytolytic activity, cell
surface phenotype, and IFN-γ production.
In one set of experiments, NK cells recovered from cocultures
were used as effectors in cytolytic assays against K562 (a classical
NK-susceptible tumor target) or autologous iDCs, which are
resistant to killing by resting NK cells. As shown in Fig. 2, NK
cells cocultured with M0, M1, and M2 neither enhanced killing
of K562 nor killed iDCs. No signiﬁcant increases of NK cyto-
toxicity could be detected in NK cells cultured with M1 in the
presence of LPS. On the contrary, NK cells cultured with M0 and
M2 in the presence of LPS displayed cytotoxicity against both
targets (Fig. 2). It is of note that the cytotoxicity of these NK cells
was similar if not greater than that of rIL-12-conditioned NK
cells. Similar results were obtained coculturing resting NK cells
with bacillus Calmette–Guérin-treated M0 or M2 (Fig. S2).
It is of note that the cytolytic activity was reduced but not
abrogated in the absence of NK-to-macrophage contact (trans-
well; M0 contact vs. transwell, P = 0.3; M2 contact vs. transwell,
P = 0.071; Fig. 2).
LPS-Treated M0 and M2 Induce Up-Regulation of CD69, CD25, and
CCR7 in Resting NK Cells. NK cells recovered after coculture with
macrophages were assessed for the expression of CD69 and CD25
activation markers. Results are depicted in Fig. 3 and a represen-
tative experiment is shown in Fig. S3A. After coculture with M1,
NK cells displayed low but signiﬁcant increases of both CD69
surface density (mean ﬂuorescence intensity, MFI) and percent of
CD69+ cells. On the contrary, after coculture with M0 or M2, NK
cells did not change CD69 expression. But when NK cells were
cultured with either M0 or M2 in the presence of LPS, the surface
density and the percent of CD69+ NK cells was strongly up-regu-
lated (Fig. 3). Regarding CD25, the MFI (but not the percent) of
positive cells was signiﬁcantly up-regulated in NK cells cocultured
with M1, but not withM0 andM2. However, both the MFI and the
percent of CD25+ cells were strongly up-regulated in NK cells
cocultured with LPS-treated M0 and M2 (Fig. 3). It is of note that
up-regulation of CD69 and CD25 was detected also in the absence
of NK-to-macrophages contacts (transwell).
Coculture with macrophages also induced the expression of
CCR7, a chemokine receptor involved in NK cell migration to
lymph nodes (21, 22). In particular, both the MFI and the per-
cent of CCR7+ cells were signiﬁcantly up-regulated after co-
culture with LPS-treated M0 and M2 cells. Different from CD69
and CD25, CCR7 expression was not induced under transwell
conditions, implying the requirement of cell-to-cell contacts (Fig.
3). Up-regulation of activation markers and CCR7 were detected
also in NK cells cocultured with bacillus Calmette–Guérin-
treated M0 or M2 cells (Fig. S3B). It is of note that, similar to
what was described for NK-DC interactions, CCR7 expression in
NK cells was accompanied by down-regulation of GPR56 (23),
Fig. 1. Susceptibility of macrophages to
lysis mediated by autologous NK cells.
(A) Short-term-activated NK cells were
analyzed at different E:T ratios for cyto-
lytic activity against autologous M0, M1,
M2, iDCs, andmDCs either in the absence
(Left) or in the presence (Right) of mAb-
mediated masking of HLA class I mole-
cules. Average of 10 independent experi-
ments. (B) Macrophages were analyzed
by ﬂow cytometry for the expression
of HLA class I molecules. Average of 11
(HLA-I) and four (HLA-E) independent
experiments. (C) Short-term-activatedNK
cells were analyzed for cytolytic activity
against autologous M0, M1, and M2 in
the presence of mAbs speciﬁc for differ-
ent triggeringNK receptors (E:T ratio 5:1).
Average of seven independent experi-
ments. SD is indicated. *P < 0.05.
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a surface molecule involved in cellular interactions with extra-
cellular matrix (Fig. S3C).
Our data indicate that M0 and M2 exposed to LPS (or bacillus
Calmette–Guérin) induce in resting NK cells an activated/mi-
gratory phenotype, which is paralleled by enhancement of their
cytolytic activity (Fig. 2).
Role of Macrophage-Derived Cytokines in the Induction of NK Cell
Activation. Resting NK cells upon exposure to rIL-12 and/or rIL-
15 increase their cytolytic activity and express activation markers
but not CCR7. Moreover, it has been described that IL-12, IL-
15, and IL-18 used alone or in combination could be involved in
NK cell activation during NK-to-DC or NK-to-macrophages in-
teraction (14, 24, 25). M0 and M2 polarizing macrophages did
not release detectable amounts of IL-12 and IL-18 (Fig. S4).
Polarization toward M1 with LPS (alone or in concert with IFN-
γ) resulted in the release of IL-12 and IL-18, as well as TNF-α
and IL-6 by both M0 and M2 cells. M1 polarized cells that (after
washing) were maintained in culture for additional 18 h released
low amounts of such cytokines and, due to endotoxin tolerance,
were no longer responsive to further TLR-mediated stimulation
(26, 27). IL-15 was undetectable in the macrophages’ super-
natants, whereas IL-15 and its receptor were expressed at the cell
membrane in M1 polarized cells and in LPS-treated M0 and M2
macrophages (Fig. S4) (15).
Thus, a correlation existed between the ability of macrophages
to release cytokines such as IL-12 and IL-18 (Fig. S4) and their
capacity to induce cytotoxicity and activation markers’ expression
in resting NK cells (Figs. 2 and 3). However, Ab-mediated
neutralization of these cytokines (as well as of IL-15) did not
modify signiﬁcantly both aspects of macrophage-mediated NK
cell activation (Fig. S5).
Regarding CCR7, it has been previously shown that it can be
induced by IL-18 and receptor uptake from CCR7+ cells (28,
29). In our experiments, CCR7 was detected in M1 but not in M0
and M2. However, polarization toward M1 with LPS resulted in
CCR7 expression also by M0 and M2 macrophages (Fig. 4A).
Remarkably, a membrane-bound form of IL-18 (mIL-18) could
be detected by cytoﬂuorimetric analysis in M0 and M2 cells.
Treatment with LPS resulted in disappearance of mIL-18, which
was paralleled by the release of soluble IL-18 in the supernatant
(Fig. S4) and acquisition of CCR7 (Fig. 4A). Interestingly,
treatment with monensin, which blocks intracellular protein
transport, did not affect LPS-induced secretion of IL-18 by mIL-
18+ macrophages, but strongly affected IL-12 release (Fig. 4B).
This ﬁnding strongly suggests that IL-18 secretion by macro-
phages depends on the release of the membrane-bound form of
IL-18 rather than on the mobilization from intracellular stores.
It is conceivable that the de novo expression of CCR7 in NK
cells may require the uptake of both CCR7 and IL-18 by NK cells
interacting with macrophages. This hypothesis is supported by
the fact that CCR7 expression was detected only in NK cells
cocultured with M0 and M2 cells (mIL-18+), which upon treat-
ment with LPS released IL-18 and expressed CCR7. This did not
occur when NK cells were cocultured with M0 and M2 (mIL-
18+, CCR7−) or M1 polarized cells (mIL-18−, CCR7+) cells,
which during polarization with LPS wasted IL-18.
LPS-Treated M0 and M2 Induce IFN-γ Release by Resting NK Cells. To
verify whether macrophages might also promote the production
of proinﬂammatory cytokines in NK cells, coculture supernatants
were analyzed for the presence of IFN-γ. As shown in Fig. 5A,
M0-, M1-, and M2-polarized cells did not induce IFN-γ pro-
duction by NK cells. Upon LPS treatment, however, M1 polar-
izing M0 and M2 promoted the release of high amounts of IFN-γ,
which was virtually abrogated in the absence of NK macrophage
contacts (i.e., under transwell conditions). Similar results were
obtained by coculturing resting NK cells with bacillus Calmette–
Guérin-treated M0 and M2 (Fig. S6). To deﬁne which molecular
interactions were involved in the induction of IFN-γ release, co-
cultures were performed in the presence of mAbs speciﬁc for dif-
ferent NK receptors or cytokines. Ab-mediate blocking of DNAM-
1 and 2B4, IL-18, or IL-18R resulted in signiﬁcant drop of IFN-γ
release (Fig. 5B). On the contrary, blocking of other receptors
(including NKG2D, NKp46, and NKp44), IL-12, and IL-15 had no
substantial effect.
Our data suggest that the various NK receptors are differently
involved in NK macrophages cross-talk. NKp46 participates
mainly to the induction of cytotoxicity against macrophages,
whereas, in line with a previous report (30), 2B4 would be pri-
marily involved in the induction of IFN-γ secretion. On the other
hand, DNAM-1 plays a dual role being involved in the induction
of both cytolytic activity and IFN-γ production.
Discussion
The present ﬁndings show that interaction between NK cells and
unpolarized, polarizing, and polarized macrophages result in
different functional outcomes. M0 (unpolarized) and M2 polar-
ized macrophages following capture of microbial products, such
as LPS and bacillus Calmette–Guérin, polarize toward M1 and
induce strong activation of resting NK cells, resulting in en-
hancement of cytolytic activity, release of high amounts of IFN-γ,
and expression of CCR7, a chemokine receptor crucial for their
recruitment into lymph nodes. NK macrophage cross-talk also
enhances the DC-editing capability (13) of NK cells, which upon
interaction with LPS or bacillus Calmette–Guérin-treated mac-
rophages become capable of killing iDCs. The editing of DCs
might be paralleled also by editing of macrophages. Indeed, M0
and M2 exposed to M1-polarizing stimuli induce NK cell activa-
tion and, in turn, activated NK cells kill M0- and M2-polarized
macrophages, which express low, nonprotective amounts of HLA
class I molecules. Conversely, M1-polarized macrophages (HLA
class I high) similarly to mDCs, are resistant to NK cells.
Regarding the soluble factors involved in the NK macrophage
cross-talk, as also reported (25), Ab-mediated neutralization of
IL-15 did not affect NK cell activation (Fig. S5). However,
Lapaque et al. (25) showed that the combined Ab-mediated
blocking of IL-12 and IL-18 inhibited CD69 expression and cy-
totoxicity in NK cells cocultured with Salmonella-infected mac-
rophages. Moreover, blocking of IL-12 alone resulted in a marked
drop of IFN-γ production. Conversely, another study showed that
during plasmodium falciparum infection, the IFN-γ production by
NK cells was IL-18 dependent (24).
In our experimental setting, optimal macrophage-mediated
induction of IFN-γ production by NK cells is dependent on cell-
Fig. 2. Analysis of the cytolytic activity of NK
cells cocultured with macrophages. After co-
culture with autologous M0, M1, and M2 (with
or without LPS), NK cells were analyzed for
cytolytic activity against K562 or autologous
iDCs either in the presence of cell-to-cell con-
tacts or in transwell (white bars). Average of
six independent experiments. *P < 0.05, **P <
0.01, ***P < 0.001.
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to-cell contacts and requires the interaction of DNAM-1 and
2B4 (on NK) with their ligands (on macrophages) as well as
IL-18 released by macrophages. Indeed, in line with Baratin
et al. (24), neutralization of IL-18 or blocking of IL-18R virtually
abrogated IFN-γ release (Fig. 5). Interestingly, the functional effect
of IL-18 on NK cells correlates with the expression, on macro-
phages, of a membrane-bound form of IL-18 (mIL-18), which is
released in small amounts after LPS treatment (Fig. 4B). It is of
note that IL-18 belongs to a cytokine family also including IL-1α,
which may remain bound to the cell membrane (31). The mo-
lecular events leading to the expression of IL-18 at the cell
surface and to its release upon stimulation are currently under
investigation.
Importantly, IL-18 appears to play a role also in the expression
of CCR7 at the NK cell surface. This event would require both the
release of IL-18 and the expression of CCR7 by macrophages.
This ﬁnding suggests the need of cooperation between IL-18 and
mechanisms of CCR7 uptake in the up-regulation of CCR7 by NK
cells (28, 29). In this context, though resting NK cells expressing
CCR7 (or CXCR3 in mice) are sensitized by TLR-stimulated
DCs in draining lymph nodes (32–35), inﬂamed or tumor tissues
could be considered as alternative sites of NK cells priming (36–
39). Indeed, the majority (>90%) of circulating human NK cells
does not express CCR7 while expressing CXCR1 and ChemR
(36). These receptors allow their recruitment in inﬂamed tissues
where they interact with monocyte-derived DCs. This results in
CXCR1 and ChemR down-regulation (36) and acquisition of
CCR7 (29), which allows their response to CCL19 and CCL21,
two chemokines that attract NK cells to secondary lymphoid
organs such as lymph nodes (21, 22). Our data support the hy-
pothesis that in injured peripheral tissues, the interaction with
pathogen-stimulated macrophages might represent a further ac-
tivation mechanism of resting NK cells leading to CCR7 acqui-
sition. Thus, it is conceivable that NK cells activated in peripheral
tissues by M1-polarizing macrophages could participate in Th1
polarization by releasing IFN-γ within lymph nodes (28, 40).
Neutralization of IL-12 did not affect signiﬁcantly the IFN-γ
release by NK cells cocultured with LPS-treated macrophages
(Fig. 5). Moreover, although in some experiments the simulta-
neous neutralization of IL-12 and IL-18 (and IL-15) reduced
CD69 expression and cytotoxicity (Fig. S5), overall, the inhi-
bition was not statistically signiﬁcant. This excludes a major role
of these cytokines in the up-regulation of activation markers and
cytotoxicity in NK cells cocultured with LPS-treated M0 (and
M2) macrophages. The discrepancy between our data and what
was observed by Lapaque et al. (25) in Salmonella infection
could depend on the type of pathogen or stimulus used to acti-
vate macrophages. In this regard, IL-12 seems to play a crucial
role in immune responses against Salmonella. Indeed, IL-12Rβ1-
deﬁcient patients show a selective susceptibility to Salmonella
infection (41).
Fig. 3. Analysis of CD69, CD25, and CCR7 expression in NK cells cocultured
with macrophages. After coculture with autologous M0, M1, and M2 (with
or without LPS), NK cells were analyzed by ﬂow cytometry for the expression
of CD69, CD25, and CCR7. The experiments were performed either in the
presence of cell-to-cell contacts or in transwell (gray symbols). Average of 10
independent experiments. Squares and triangles indicate the MFI and the
percentage of positive cells, respectively.
Fig. 4. Analysis of mIL-18 expression and release by macrophages. (A)
Macrophages either untreated or LPS treated were analyzed by ﬂow
cytometry for mIL-18 and CCR7 expression. (B) M0 were treated at the in-
dicated time intervals with LPS in the absence (open symbols) or in the
presence (black symbols) of monensin. Cell culture supernatants were ana-
lyzed by ELISA for the presence of IL-18 (triangle) and IL-12 (square). Aver-
age of three independent experiments (Left). The analysis was paralleled by
the cytoﬂuorimetric analysis of mIL-18 surface expression (Right). The mean
MFI is indicated.
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Thus, IL-18 plays a central role in IFN-γ release and CCR7
expression by NK cells interacting with macrophages activated by
LPS or bacillus Calmette–Guérin. However, the identity of the
soluble factor(s) playing a pivotal role in up-regulation of NK
cell activation markers and cytotoxicity remain to be determined.
Interestingly, during Salmonella and plasmodium falciparum in-
fection, macrophage-mediated activation of NK cells required
preactivation of NK cells with suboptimal doses of cytokines such
as rIL-12, rIL-15, or rIL-2 (24, 25). In our experimental setting,
LPS and bacillus Calmette–Guérin-treated macrophages were
able to activate resting unconditioned NK cells. The discrepancy
could be attributed to the inability of given pathogens or stimuli
to induce full M1 polarization of macrophages. For example, in
our hands, macrophages treated with LPS alone or in concert
with IFN-γ acquired classical M1 phenotype and function,
whereas treatment with IFN-γ alone resulted in incomplete po-
larization of macrophages (Fig. S7). Thus, the “ménage à trois,”
e.g., the presence of a third partner (such as DCs or T cells)
secreting NK cell-priming cytokines (25) might be necessary or
dispensable, depending on the type of pathogen or stimulus
acting on macrophages.
Overall, our data suggest that in type 1-oriented immune
responses (15, 16), NK cells may play a role in amplifying both
innate and adaptive responses, as a result of their interaction not
only with maturing DCs but also with M1-polarizing macrophages.
In this context, it is of note that macrophage activation by
pathogens through pattern recognition receptors such as TLR4 is
regulated by feedback mechanisms that prevent overexuberant
inﬂammation (26, 27). After exposure to LPS, macrophages enter
into a transient unresponsive state and are unable to respond to
further challenges with endotoxins (endotoxin tolerance). This
phenomenon may play a protective role on the host against en-
dotoxin shock. Endotoxin-tolerant macrophages present a gene
reprogramming toward an M2-like functional phenotype, which
includes increased expression of anti-inﬂammatory cytokines (IL-
10, TGF-β, IL-1Rα) and reduced expression of proinﬂammatory
ones. In our experiments, M1 cells that (after washing) were
maintained in culture for additional 18 h and further stimulated
with LPS did not express mIL-18, released negligible amounts of
cytokines, such as IL-12 and IL-18, and were unable to activate
resting NK cells. Lack of NK cell activation could result in drop of
IFN-γ production, a further mechanism that prevents excessive
inﬂammatory responses.
Similar to M0, M2, although expressing mIL-18, do not ex-
press CCR7; do not release proinﬂammatory cytokines such as
IL-18 and IL-12; and are unable to induce NK cell function.
Accordingly, TAM, frequently characterized by a M2-like po-
larized phenotype and set in a cancer-promoting mode (17),
might also be unable to cooperate with NK cells. However, it is
noteworthy that M2 are neither terminally differentiated nor
“exhausted” cells. Thus, microbial products could revert their
functional M2 phenotype toward an immunostimulatory M1-
oriented one. Indeed, our present data show that in LPS (or
bacillus Calmette–Guérin)-treated M2, the expression of CCR7
and the release of cytokines, including IL-12 and IL-18, was
accompanied by a de novo ability to induce, in resting NK cells,
expression of activation markers and CCR7, release of IFN-γ,
and enhancement of cytotoxicity. This shows that M2 are char-
acterized by a remarkable functional plasticity, because they can
be rescued from their immunomodulatory state and shaped to-
ward the capacity to induce NK cell activation. Reprogramming
TAM vs. M1 phenotype and function represents an interesting
strategy to restore antitumor responses. For example, the use of
CpG and anti-IL-10R antibodies promoted innate responses in
tumor-bearing mice (42), and bacillus Calmette–Guérin immu-
notherapy provided substantial clinical beneﬁts in ovarian and
Fig. 5. Molecular interactions involved in themacrophage-
mediated induction of IFN-γ release by NK cells. (A) NK
cells were coculturedwithM0,M1, andM2 (with orwithout
LPS) either in the presence of cell-to-cell contacts (Left) or in
transwell (Right). Supernatants were analyzed by ELISA
for the presence of IFN-γ. Average of 13 (contact) and four
(transwell) independent experiments. (B) NK cells were
cocultured with M0 and M2 in the presence of LPS and
the indicated blocking/neutralizing antibodies. Superna-
tants were analyzed by ELISA for the presence of IFN-γ. Av-
erage of ﬁve independent experiments.
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bladder cancer patients (43, 44). It is tempting to speculate that
restoration of M1 polarization of cancer-propelling TAM might
also induce an effective antitumor activity of NK cells. Indeed,
reprogramming M2-oriented TAM vs. M1 could also result in
strong NK cell activation, which, in turn, would promote type-1
immune responses, NK-mediated editing of DCs and macro-
phages. Moreover, activated NK cells could exert a potent cy-
tolytic activity not only against cancer cells but also against
residual TAM, as suggested by the high susceptibility of M2
macrophages to NK-mediated lysis (Fig. 2).
In conclusion, the interaction between NK cells and M1-
polarizing M0 and M2 macrophages emerges as a unique and
potentially relevant component of activation, ampliﬁcation, and
regulation of innate and adaptive responses.
Materials and Methods
NK/Macrophage Cocultures. Cells used in the study are described in SI
Materials and Methods.
M0, M1, and M2 cells were washed ﬁve times with 10% FCS containing
medium and cocultured overnight with autologous resting NK cells with or
without 100 ng/mL LPS or bacillus Calmette–Guérin (1:1 bacillus Calmette–
Guérin:macrophage ratio). The NK:macrophage ratio used was 1:1. Trans-
well experiments were performed using 24-well transwell plates (0.4-μm
pore size; Corning Costar). In each well, 0.5 × 105 macrophages (with or
without LPS or bacillus Calmette–Guérin) and 0.5 × 105 NK cells were placed
in the bottom and the upper chamber, respectively.
Flow Cytoﬂuorimetric Analysis, Cytolytic Assays, and Cytokines Release. For
cytoﬂuorimetric analysis (FACSCalibur; Becton Dickinson), cells were stained
with PE- or FITC-conjugated mAbs or with unconjugated mAbs followed by
PE-conjugated isotype-speciﬁc goat anti-mouse second reagent (Southern
Biotechnology). Macrophages and DCs were preincubated for 30 min at 4 °C
with hIgG (1 mg/mL; Jackson ImmunoResearch Laboratories) before speciﬁc
mAb staining.
NK cells were tested for cytolytic activity in a 4-h 51Cr-release assay as
previously described (7) at the indicated E/T ratios.
ELISA kits used were: IFN-γ, TNF-α, IL-12p40/p70, IL-15, IL-6 (BioSource
International, Inc.), and IL-18 (Medical Biological Laboratories).
Ab-mediated blocking/neutralization experiments were performed add-
ing saturating amounts of Abs at the onset of the cell cultures. mAbs of IgM
isotype were used, when available, to avoid nonspeciﬁc cross-linking of
Fc receptors.
Monensin (BD Bioscience) treatment was performed according to the
manufacturer’s procedures. Brieﬂy, 0.5 × 106 M0 cells were cultured at var-
ious time intervals with LPS and monensin (1:5,000 dilution).
Antibodies used in the study and statistical analysis are described in SI
Materials and Methods.
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